NeoStem is a New York City-based cell therapy company that engages in the development of proprietary therapy products. The company offers cell product and process development, cell and tissue processing, regulatory support, storage, distribution and deliver, and consulting services to clients in the regenerative medicine industry, amongst others. Its products have been used to treat diseases such as diabetes, asthma, lupus, and multiple sclerosis. For more information, please visit the company’s website at www.neostem.com.